acetamiprid - Exposure Details | CTD
Skip navigation

Chemical acetamiprid

These are exposure details associated with the chemical and all of its children.



1–18 of 18 results.
  Reference Exposure Stressor Number of Receptors Receptors Receptor Notes Medium Exposure Marker Marker Level Measurement Statistic Assay Notes Country Outcome Relationship Disease Phenotype
1. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid <LOD 25th percentile Japan
2. Marfo JT, et al. (2015). acetamiprid 85 Subjects with disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 1.2 nanograms per milliliter median Japan
3. Marfo JT, et al. (2015). acetamiprid 85 Controls for disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid Japan positive correlation Neurologic Manifestations
4. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.36 micrograms per liter maximum Japan
5. Marfo JT, et al. (2015). acetamiprid 85 Controls for disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 6 nanograms per milliliter maximum Japan
6. Marfo JT, et al. (2015). acetamiprid 85 Controls for disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 0.62 nanograms per milliliter minimum Japan
7. Marfo JT, et al. (2015). acetamiprid 19 Subjects with disease:Neurologic Manifestations typical symptomatic group urine N-desmethylacetamiprid 6 parts per billion maximum Japan
8. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.18 micrograms per liter 95th percentile Japan
9. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid <LOD geometric mean Japan
10. Marfo JT, et al. (2015). acetamiprid 16 Subjects with disease:Neurologic Manifestations atypical symptomatic group urine N-desmethylacetamiprid 4.4 parts per billion maximum Japan
11. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid <LOD 5th percentile Japan
12. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.06 micrograms per liter 75th percentile Japan
13. Marfo JT, et al. (2015). acetamiprid 85 Controls for disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 1.2 nanograms per milliliter median Japan
14. Marfo JT, et al. (2015). acetamiprid 85 Subjects with disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid Japan positive correlation Neurologic Manifestations
15. Marfo JT, et al. (2015). acetamiprid 85 Subjects with disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 6 nanograms per milliliter maximum Japan
16. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.02 micrograms per liter 50th percentile Japan
17. Marfo JT, et al. (2015). acetamiprid 85 Subjects with disease:Neurologic Manifestations all three groups (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 0.62 nanograms per milliliter minimum Japan
18. Marfo JT, et al. (2015). acetamiprid 50 Controls for disease:Neurologic Manifestations non-symptomatic group urine N-desmethylacetamiprid 2.2 parts per billion maximum Japan
1–18 of 18 results.